19
Supernus Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is TOPIRAMATE, with a corresponding application number 201635.
Regulatory Information RX
With a dosage strength 200MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2013-08-16
Therapeutic Equivalence (TE) Code AB1
18
Supernus Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is TOPIRAMATE, with a corresponding application number 201635.
Regulatory Information RX
With a dosage strength 50MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2013-08-16
Therapeutic Equivalence (TE) Code AB1
17
Supernus Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is TOPIRAMATE, with a corresponding application number 201635.
Regulatory Information RX
With a dosage strength 100MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2013-08-16
Therapeutic Equivalence (TE) Code AB1
16
Supernus Pharmaceuticals, based in U.S.A, is a pharmaceutical company.
One of their notable products is TOPIRAMATE, with a corresponding application number 201635.
Regulatory Information RX
With a dosage strength 25MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2013-08-16
Therapeutic Equivalence (TE) Code AB1